-
Mashup Score: 1IPOS - 2 year(s) ago
IPOS is a four-day meeting covering the spectrum of pediatric and adolescent orthopaedic conditions. Presented by POSNA.
Source: IPOSCategories: Latest Headlines, OrthopedicsTweet
-
Mashup Score: 0IPOS - 2 year(s) ago
IPOS is a four-day meeting covering the spectrum of pediatric and adolescent orthopaedic conditions. Presented by POSNA.
Source: IPOSCategories: Latest Headlines, OrthopedicsTweet-
Don't miss out! Registration rates increase tonight. Register now: https://t.co/I3VlL6lpmP #IPOS2022 #posna #pediatricorthopaedics
-
-
Mashup Score: 0IPOS - 2 year(s) ago
IPOS is a four-day meeting covering the spectrum of pediatric and adolescent orthopaedic conditions. Presented by POSNA.
Source: IPOSCategories: Latest Headlines, OrthopedicsTweet-
Registration rates increase on November 1, 2022! Register now: https://t.co/X7Idwnspuc https://t.co/T8erioTdVq #posna #ipos2022 #pediatricorthopaedics
-
-
Mashup Score: 0IPOS - 2 year(s) ago
IPOS is a four-day meeting covering the spectrum of pediatric and adolescent orthopaedic conditions. Presented by POSNA.
Source: IPOSCategories: Latest Headlines, OrthopedicsTweet-
Have you viewed the preliminary program for #IPOS2022? Registration rates will increase on November 1, 2022: https://t.co/3CBbtwlz5J #posna #pediatricorthopaedics #handsonlearning #education https://t.co/Fwc7DKdf98
-
-
Mashup Score: 0IPOS - 2 year(s) ago
IPOS is a four-day meeting covering the spectrum of pediatric and adolescent orthopaedic conditions. Presented by POSNA.
Source: IPOSCategories: Latest Headlines, OrthopedicsTweet-
IPOS® has a NEW program featuring IPOS® Director Suken A. Shah, MD & James McCarthy, MD, included with full registration or purchased separately. Learn More & Register today: https://t.co/3CBbtwD9Xh *Registration rates increase on November 1, 2022 #posna #ipos2022 #pedsortho https://t.co/YLFDvUWLju
-
-
Mashup Score: 0IPOS - 2 year(s) ago
IPOS is a four-day meeting covering the spectrum of pediatric and adolescent orthopaedic conditions. Presented by POSNA.
Source: IPOSCategories: Latest Headlines, OrthopedicsTweet-
Immerse yourself in this exciting and interactive four-day program alongside hundreds of pediatric orthopaedic professionals from around the world this December 6-10 in Orlando, FL. Learn more & Register: https://t.co/X7IdwnsXjK #pediatricorthopaedics #IPOS2022 #posna https://t.co/BW2P0siDmp
-
-
Mashup Score: 0IPOS - 2 year(s) ago
IPOS is a four-day meeting covering the spectrum of pediatric and adolescent orthopaedic conditions. Presented by POSNA.
Source: IPOSCategories: Latest Headlines, OrthopedicsTweet-
What do you like best about IPOS®? Learn more & Register: https://t.co/X7IdwnsXjK #pediatricorthopaedics #IPOS2022 #posna #APP #advancedpractice #nursepractitioner https://t.co/aEZN1UPJZL
-
-
Mashup Score: 0IPOS - 2 year(s) ago
IPOS is a four-day meeting covering the spectrum of pediatric and adolescent orthopaedic conditions. Presented by POSNA.
Source: IPOSCategories: Latest Headlines, OrthopedicsTweet-
Have you registered yet? December 6-10 in Orlando, FL Learn more & Register: https://t.co/X7Idwnspuc #residents #fellows #pediatricorthopaedics #ipos2022 #posna https://t.co/cd5HTfpPIa
-
-
Mashup Score: 0IPOS - 2 year(s) ago
IPOS is a four-day meeting covering the spectrum of pediatric and adolescent orthopaedic conditions. Presented by POSNA.
Source: IPOSCategories: Latest Headlines, OrthopedicsTweet-
Registration and Housing now open! https://t.co/3CBbtwlz5J #posna #ipos2022 #pediatricorthopaedics https://t.co/SAnjo62Yfa
-
-
Mashup Score: 2IPOS - 2 year(s) ago
IPOS is a four-day meeting covering the spectrum of pediatric and adolescent orthopaedic conditions. Presented by POSNA.
Source: IPOSCategories: Latest Headlines, OrthopedicsTweet-
Scholarship deadline is tonight! https://t.co/FjwXMY17c7 #IPOS2022 https://t.co/rbGJb60RnS
-
IPOS® is less than a month away! Join #POSNA in Orlando this December 6-10. Customize your learning experience to your unique practice needs: https://t.co/WZmK2Mp5Il #ipos2022 #pediatricorthopaedics @mpayareslizano https://t.co/bLnEvwkPdt